Press "Enter" to skip to content

New patent for Vanda Pharms drug HETLIOZ

0

Annual Drug Patent Expirations for HETLIOZ
Annual Drug Patent Expirations for HETLIOZ

Hetlioz is a drug marketed by Vanda Pharms Inc
and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

This drug has eigthy-three patent family members in twenty-nine countries.

The generic ingredient in HETLIOZ is tasimelteon. One supplier is listed for this compound. Additional details are available on the tasimelteon profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

    Do NOT follow this link or you will be banned from the site!